You have 9 free searches left this month | for more free features.

NTRK1

Showing 1 - 25 of 86

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer

Recruiting
  • Thyroid Cancer
  • NTRK fusion assessment
  • Roma, Italy
    Regina Elena National Cancer Institute
Mar 31, 2023

Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Providence (TY-2136b)

Not yet recruiting
  • Locally Advanced Solid Tumor
  • Metastatic Solid Tumor
  • Providence, Rhode Island
    Rhode Island Hospital, Brown University
Mar 2, 2023

NTRK Family Gene Mutation Trial in Germany

Recruiting
  • NTRK Family Gene Mutation
    • Berlin, Germany
    • +22 more
    Jan 18, 2023

    Advanced Solid Tumor, Metastatic Solid Tumor Trial in Canton (TPX-0005, Metformin Hydrochloride, Digoxin)

    Recruiting
    • Advanced Solid Tumor
    • Metastatic Solid Tumor
    • Canton, Ohio
      Gabrail Cancer Research Center
    Apr 25, 2023

    Soft Tissue Sarcoma, Advanced Cancer, Metastatic Cancer Trial in France (Blood and tumor samples)

    Recruiting
    • Soft Tissue Sarcoma
    • +2 more
    • Blood and tumor samples
    • Clermont-Ferrand, France
    • +9 more
    Dec 8, 2021

    Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Korea, Republic of, United States (Entrectinib)

    Completed
    • Locally Advanced Solid Tumors
    • Metastatic Solid Tumors
    • Orange, California
    • +9 more
    Jun 7, 2021

    Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma Trial in Worldwide (Oral repotrectinib (TPX-0005))

    Recruiting
    • Locally Advanced Solid Tumors
    • +3 more
    • Oral repotrectinib (TPX-0005)
    • Los Angeles, California
    • +27 more
    Aug 9, 2022

    Locally Advanced or Metastatic Solid Tumors, Locally Advanced or Metastatic NSCLC Trial in Beijing (XZP-5955 tablets)

    Recruiting
    • Locally Advanced or Metastatic Solid Tumors
    • Locally Advanced or Metastatic Non-small Cell Lung Cancer
    • XZP-5955 tablets
    • Beijing, Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciences
    May 17, 2022

    Advanced Solid Malignant Tumors Trial in Fukuoka, Osaka, Tokyo (DS-6051b)

    Active, not recruiting
    • Advanced Solid Malignant Tumors
    • Fukuoka, Japan
    • +2 more
    Jan 18, 2022

    Solid Tumors Harboring NTRK Fusion Trial in Worldwide (Selitrectinib (BAY2731954))

    Active, not recruiting
    • Solid Tumors Harboring NTRK Fusion
    • Selitrectinib (BAY2731954)
    • La Jolla, California
    • +28 more
    Aug 18, 2022

    Cancer, Cancer Metastatic, NTRK Gene Fusion Overexpression Trial in Worldwide (Data collection and quality of life

    Recruiting
    • Cancer
    • +15 more
    • Data collection and quality of life questionnaire
    • Graz, Austria
    • +40 more
    Jul 27, 2021

    High Grade Glioma, Diffuse Intrinsic Pontine Glioma Trial in Worldwide (Larotrectinib, Larotrectinib surgical)

    Recruiting
    • High Grade Glioma
    • Diffuse Intrinsic Pontine Glioma
    • Aurora, Colorado
    • +17 more
    Aug 10, 2022

    Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion Trial in Shanghai (SIM1803-1A)

    Recruiting
    • Advanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion
    • Shanghai, China
      Shanghai Chest Hospital
    Jan 11, 2021

    Solid Tumors Harboring NTRK Fusion Trial in Worldwide (Larotrectinib (Vitrakvi, BAY2757556))

    Recruiting
    • Solid Tumors Harboring NTRK Fusion
    • Larotrectinib (Vitrakvi, BAY2757556)
    • Los Angeles, California
    • +50 more
    Jan 29, 2023

    Solid Tumors Harboring NTRK Fusion Trial in United States (Larotrectinib (Vitrakvi, BAY2757556))

    Completed
    • Solid Tumors Harboring NTRK Fusion
    • Larotrectinib (Vitrakvi, BAY2757556)
    • Aurora, Colorado
    • +7 more
    May 11, 2021

    Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Worldwide (Oral repotrectinib (TPX-0005))

    Recruiting
    • Locally Advanced Solid Tumors
    • Metastatic Solid Tumors
    • Oral repotrectinib (TPX-0005)
    • Yuma, Arizona
    • +175 more
    Jan 25, 2023

    Solid Tumors, CNS Tumors Trial in Worldwide (Entrectinib)

    Recruiting
    • Solid Tumors
    • CNS Tumors
    • Orange, California
    • +38 more
    Aug 24, 2022

    Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

    Recruiting
    • Breast Cancer
    • +15 more
    • Goodyear, Arizona
    • +146 more
    Aug 24, 2022

    Solid Tumors Harboring NTRK Fusion Trial in Worldwide (BAY2757556 (Larotrectinib, Vitrakvi))

    Recruiting
    • Solid Tumors Harboring NTRK Fusion
    • BAY2757556 (Larotrectinib, Vitrakvi)
    • Palo Alto, California
    • +158 more
    Aug 8, 2022

    NSCLC, Solid Tumor Trial in Boston (Merestinib)

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Solid Tumor
    • Boston, Massachusetts
    • +1 more
    Jan 26, 2022

    ALK Fusion Protein Expression, BRAF wt Allele, Invasive Skin Melanoma Trial in San Francisco (Capmatinib, Ceritinib,

    Terminated
    • ALK Fusion Protein Expression
    • +14 more
    • San Francisco, California
      University of California, San Francisco
    Jan 14, 2020

    Solid Tumors Trial in United States (DS6051b)

    Completed
    • Solid Tumors
    • Scottsdale, Arizona
    • +5 more
    Sep 18, 2020

    Solid Tumors Harboring NTRK Fusion Trial (Selitrectinib (BAY2731954))

    No longer available
    • Solid Tumors Harboring NTRK Fusion
    • Selitrectinib (BAY2731954)
    • (no location specified)
    Sep 8, 2021

    Solid Tumor Trial (TL118 Capsule)

    Not yet recruiting
    • Solid Tumor
    • TL118 Capsule
    • (no location specified)
    Aug 18, 2023